Sentence examples for agents of progression from inspiring English sources

Whilst in latter stages the audience can act as agents of progression to encourage higher skill levels of movement, much emphasis is placed on the ability to abstain from adapting to the perceived expectations of the audience.

This observed survival difference was despite the fact that nearly three-quarters of patients treated initially with chemotherapy alone crossed over to herceptin as a single agent on progression of disease.

As described previously, Discovery Phase cases were diagnosed with histologically confirmed BE and ascertained through the UK-based Aspirin Esomeprazole Chemoprevention Trial (AspECT) in Barrett's Metaplasia, a clinical trial of proton-pump inhibitor (esomeprazole) and aspirin as preventive agents for progression of BE to EAC.

Such flexibility re-emerges under the term 'phenotype plasticity' and entails a departure from the classical mutations/selection scheme as an agent of tumour progression.

By representing the grid as a tensor whose vectors are properties of the included agents, the progression of the tensor could be visualized using the advanced imaging platform DIPimage (Image Processing Toolbox for Matlab, Delft University of Technology, Delft, The Netherlands).

Therefore, it is important to include disease progression in the model in order to study the long-term effect of antidiabetic agent at different stages of progression.

Conflicting relationships have been described between anemia correction using erythropoiesis-stimulating agents and progression of chronic kidney disease (CKD).

Does the selectivity and order of neurodegeneration in PD reflect differential sensitivity to environmental agents or some other mechanism of progression such as prion-like spreading (Dunning et al. 2012)?

12 Furthermore, after more than 2.5 years of discontinuing docetaxel, two patients with mCRPC continue to be treated with single-agent dasatinib with no evidence of progression by radiographic studies.

Clinically, patients treated with targeted agents may often first show signs of progression in bone metastases (Plimack et al, 2009).

Patients with resistant focal segmental glomerulosclerosis (FSGS) who are unresponsive to corticosteroids and other immunosuppressive agents are at very high risk of progression to end stage kidney disease.